Buys
Open market- Shares
- Avg price
- Total value
Matthew K. Szot - Chief Financial Officer at Cadrenal Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- CVKD on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Matthew K. Szot in Cadrenal Therapeutics, Inc.
Sells
Open market- Shares
- -33,333
- Avg price
- $11.92
- Total value
- -$397,455
Net
Past year- Shares
- -33,333
- Share %
- -100%
- Total value
- -$397,455
Reported holdings for Matthew K. Szot in Cadrenal Therapeutics, Inc.
Form 4 holding
Chief Financial Officer
Cadrenal Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 29 Dec 2025
- Price
- $6.97
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
Cadrenal Therapeutics, Inc.
- Security class
- Stock Options
- Shares / value
- 50,000
- Estimated value
- Report date
- 23 Jan 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Matthew K. Szot in Cadrenal Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.